abstracts

0

Page précédente

Abstracts Lille 2003

Type présentation Jour N° Session N°communication Auteurs Titre Adresses
Orale Lundi 14/04    2 O11 MN Beyens (1); C Guy (1); M Ratrema (1); G Mounier (1); M Ollagnier (1); FRENCH NATIONAL MONITORING PROGRAMME AFTER ONE YEAR OF ZYBAN
Abstract complet
(1) Centre de Pharmacovigilance, CHU Saint-Etienne Bellevue, SAINT-ETIENNE;
Orale Lundi 14/04    2 O12 C Le Beller (1); S Henry (1); M Levée (2); G Derrien (3); C Le Maignan (4); E Levy (4); B Bonan (2); A Lillo-Le Louët (1); ASSESSMENT AFTER 12-MONTHS OF SYSTEMATIC REPORT OF CANCER TREATMENT ADVERSE DRUG REACTIONS
Abstract complet
(1) Centre Régional de Pharmacovigilance, Hôpital Européen Georges Pompidou, PARIS; (2) Pharmacie, Hôpital Européen Georges Pompidou, PARIS; (3) Oncologie-Radiothérapie, Hôpital Européen Georges Pompidou, PARIS; (4) Oncologie Médicale, Hôpital Européen Georges Pompidou, PARIS;
Orale Lundi 14/04    2 O13 ML Laroche (1); M Amaniou (1); O Chaput (1); Y Nouaille (1); L Merle (1); CONSUMERS ASSOCIATION AND MEDICAL REPORTS ON CERIVASTATIN-INDUCED MUSCLE DISORDERS
Abstract complet
(1) Centre Régional de Pharmacovigilance, CHU Dupuytren, LIMOGES;
Orale Lundi 14/04    2 O14 R Serreau (1); A Liutkus (1); F Menez (2); V Baudouin (3); D Luton (4); E Jacqz-Aigrain (1); ADVERSE EFFECTS OF ACE INHIBITORS AND AT1 RECEPTOR BLOCKERS DURING PREGNANCY
Abstract complet
(1) Pharmacology Unit, Robert Debré Hospital, PARIS; (2) Foetopathology unit, Robert Debré Hospital, PARIS; (3) Nephrology Unit, Robert Debré Hospital, PARIS; (4) Gynecology-Obstetrics Unit, Robert Debré Hospital, PARIS;
Orale Lundi 14/04    2 O15 H Saissi (1); AP Jonville-Bera (1); F Beau-Salinas (1); G Lorette (2); E Autret-Leca (1); DRUG-INDUCED ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS
Abstract complet
(1) Centre Régional de Pharmacovigilance, CHRU Tours, TOURS; (2) Service de Dermatologie, CHRU, TOURS;
Orale Lundi 14/04    2 O16 K Martin (1); S Lawson-Ayayi (2); G Miremont-Salamé (1); MJ Blaizeau (3); D Lacoste (3); M Dupon (3); T Schaverberke (4); P Mercié (3); JM Ragnaud (3); F Haramburu (1); F Dabis (2); ASEPTIC OSTEONECROSIS IN HIV-INFECTED PATIENTS, AQUITAINE COHORT 1999 – 2002
Abstract complet
(1) Centre Régional de Pharmacovigilance, Département de Pharmacologie, Université Victor Segalen, CHU, BORDEAUX; (2) INSERM U330, Université Victor Segalen Bordeaux 2, BORDEAUX; (3) Centre d’Information et de Soins sur l’Immunodéficience Humaine, CHU, BORDEAUX; (4) Service de Rhumatologie, CHU, BORDEAUX;
Orale Lundi 14/04    2 O17 S Lugardon (1); K Desboeuf (2); P Fernet (2); JL Montastruc (1); M Lapeyre-Mestre (1); ASSESSING THE PREVALENCE OF ADVERSE DRUG REACTIONS IN A FRENCH UNIVERSITY HOSPITAL : A CAPTURE-RECAPTURE STUDY USING DATA FROM PMSI AND THE FRENCH PHARMACOVIGILANCE DATABASE
Abstract complet
(1) Service de Pharmacologie Clinique, Faculté de Médecine, TOULOUSE; (2) Fédération d’Informatique Médicale et d’Evaluation, CHU, TOULOUSE;
Orale Lundi 14/04    2 O18 G Pietri (1); E Van Ganse On Behalf Of The Euro-Med-Stat Group (1); EURO-MED-STAT: MONITORING EXPENDITURE AND UTILISATION OF MEDICINAL PRODUCTS IN THE EUROPEAN UNION COUNTRIES. A PUBLIC HEALTH APPROACH
Abstract complet
(1) Unité de Pharmacoépidémiologie, Centre Hospitalier Universitaire Lyon Sud, PIERRE-BENITE;
Orale Lundi 14/04    2 O19 P Mismetti (1); JM Yeguiayan (1); S Quenet (1); B Tardy (2); S Laporte (1); H Decousus (1); PHARMACOEPIDEMIOLOGY OF INITIAL ANTICOAGULANT THERAPY OF DEEP-VEIN THROMBOSIS: RISK ASSESSMENT OF MAJOR HAEMORRHAGES BASED ON INDIVIDUAL DATA FROM 5 RANDOMISED TRIALS
Abstract complet
(1) Unité Pharmacologie Clinique, EA3065, CHU Saint-Etienne Bellevue, SAINT-ETIENNE; (2) Service Urgences et Réanimation Médicale, EA3065, CHU Saint-Etienne Bellevue, SAINT-ETIENNE;
Orale Lundi 14/04    2 O20 E Rahme (1); AN Barkun (2); YM Toubouti (1); M Bardou (2); SPECIFIC COX-2 INHIBITORS ROFECOXIB AND CELECOXIB MAY PREVENT COLORECTAL ADENOMAS OCCURRENCE AND RECURRENCE. A NESTED CASE-CONTROL STUDY
Abstract complet
(1) Clinical Epidemiology Unit, McGill University Health Center, MONTREAL, CANADA; (2) Gastroenterology Department, McGill University Health Center, MONTREAL, CANADA;

Page précédente